Metastatic Alveolar Soft Part Sarcoma
Also known as: Alveolar soft part sarcoma metastatic
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11595 | Atezolizumab | A monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11595 | Atezolizumab | Programmed cell death 1 ligand 1 | target |
| DB11595 | Atezolizumab | Programmed cell death protein 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11595 | Atezolizumab | 1 | Not Yet Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Recruiting | 3 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB01175 | Escitalopram | 2 | Recruiting | 1 |
| DB06589 | Pazopanib | 2 | Terminated | 1 |
| DB11942 | Selinexor | 2 | Recruiting | 1 |